Navigation Links
CBDM.T, The Market and Business Intelligence Company Reviews The Dry Eye Disease Treatment Market
Date:4/28/2010

According to CBDM.T®, the market and business intelligence company, the Dry Eye market is huge and growing valued at 1.7 billion USD in 2009 with an annual growth of about 10 to 11%. The Dry Eye market could account for more than 2.4 billion USD by 2014.

Paris, France (PRWEB) April 28, 2010 -- Dry eye disease (DED) is one of the most frequently encountered ocular morbidities. 25 % percent of patients who visit ophthalmic clinics report symptoms of dry eye, making it a growing public health problem and one of the most common conditions seen by eye care practitioners. Dry eye affects an estimated 20 to 30 million people in the United States and is one of the most common reasons that people visit their eye doctor. Dry eye’s prevalence estimation is very variable but we could estimate that more than 70 million people are or will be affected by dry ocular symptoms. According to CBDM.T, Dry Eye represents one of the fastest growing pharmaceutical product categories in the ophthalmology market at over 10% growth per annum to 2014. The market potential for dry eye drugs is projected to reach 1 billion USD by 2015.

The first line of treatment is usually eye drops that act as artificial tears and give some temporary relief. Restasis (cyclosporine A ophthalmic emulsion) 0.05% is the first approved prescription product in the United States for the treatment of dry eye disease. Restasis (Allergan) sales were 270 million USD in 2006s to 444 million USD by 2008.

In 2008, more than 15 products were under development from discovery, preclinical, clinical phase 1, clinical phase 2 (5 products) to clinical phase 3 with 8 products. The leading companies in this market are Novartis, Alcon (acquired by Novartis), Bausch & Lomb, Vistakon (J&J), Allergan, Pfizer and AMO (Abbott Medical Optics Inc).

According to CBDM.T®, the market and business intelligence company, the Dry Eye Disease (DED) market is huge and growing valued at 1.7 billion USD in 2009 with an annual growth of about 10 to 11%. The Dry Eye Disease (DED) market could account for more than 2.4 billion USD by 2014. If we look at treatments and products, there is no cure for dry eyes syndrome. There are different products to moderate the dryness of the eye. For mild and moderate cases, supplemental lubrication is the main part of the treatment. Inflammation occurring in response to tears film hypertonicity can be suppressed by mild topical steroids or with topical immunosuppressants such as cyclosporine.

The main pharmaceutical companies have recently attempted to acquire market share. In 2010, Novartis bought Alcon’s remaining 52% for $28.1 billion (now making 77%). “The first line of treatment is usually eye drops. We estimate the market for artificial tears at more than one billion USD this year. Eye drops act as artificial tears and give temporary relief, but there is no cure for dry eye syndrome” comments Philippe Tramoy, managing partner.

Key players: Alcon, Allergan, Bausch&Lomb, Novartis, Ocusoft, Eagle Vision, Oasis Medical, Santen, Novagali Pharma, Opko Health, Sirion Therapeutics, Alacrity Biosciences, Eyegate Pharma, Resolvyx Pharmaceuticals, Sunesis Pharmaceuticals, Biocis Pharma, Argentis Pharmaceuticals.

Detailed products: Prolacria, Rebamipide, Ecabet Sodium, Vekacia, Vismed, Civamide, ST-603, ALTY-0501, AL-2178 FID109980, EGP-437, RX-10045, SAR-1118

If you need market and business intelligence services in the Dry Eye Disease market, please contact us at contact@cbdmt.com or you can also buy our latest Dry Eye Disease (DED) Report on DED.

CBDM.T® - Market and Business Intelligence- is a market and business intelligence company with offices in France, Switzerland and in Israel. As an advisory services company, CBDM.T® boosts companies to develop revenue and growth by providing business and marketing services in the life science and biotech markets (market surveys, market scouting, business development and strategic supports).

For more information:

CBDM.T® Market and Business Intelligence
88-90 rue de la Mare
Fr-75020 Paris - France
Tel : +33 1 4474 7957
Email: contact(at)cbdmt(dot)com
Web site: CBDM.T®

More information on www.dry-eye-disease.com

Next focus: Alzheimer Market

###

Read the full story at http://www.prweb.com/releases/cbdmt/dryeyedisease/prweb3924374.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. InBoundMarketingPR: Cord Blood America Newest Inbound Marketing Client
2. Top DTC Marketers Choose Obama Over Romney and Palin
3. Industry Veteran Bob O'Hara to Share Insights on Enterprise WLAN Market at Interop Las Vegas 2010
4. Peoria and Baltimore Serve as Test Markets for New Spot On Energy Product
5. Human Touch Returns to High Point Market with the First iPhone/iPod Touch Controlled Massage Chair
6. Global Dental Laboratories Market to Exceed $14.5 Billion by 2015, According to New Report by Global Industry Analysts, Inc.
7. 10,000 New, Reusable Advertising and Promotional Items Extend Marketing Muscle, Free 24-Hour Rush Service
8. Interact Marketing to Provide Online Services for England, Inc.
9. Chiropractic Traffic CEO Matt Prados Releases the Easiest and Fastest Free Chiropractic Marketing Method Known to Man
10. Donors Welcome the Advance Market Commitment's First Long-Term Supply Commitments
11. Ziosoft Expands PhyzAiodynamic Diagnostic Solutions into Greek Healthcare Market
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
CBDM.T, The Market and Business Intelligence Company Reviews The Dry Eye Disease Treatment Market 
(Date:3/24/2017)... ... March 24, 2017 , ... The law firm of ... N.Y., is pleased to announce Westchester resident Lauren C. Enea has joined the firm ... the firm, will concentrate her practice in elder law, Medicaid planning and applications, and ...
(Date:3/24/2017)... ... 2017 , ... Viewers who like to educate themselves on current issues and ... services, and societal issues tend to appreciate and love the "Informed" series, hosted by ... running events for causes around the world. , Running for charity has ...
(Date:3/24/2017)... (PRWEB) , ... March 24, 2017 , ... ... ( http://www.hygieacare.com ) announced their partnership to prep patients for colonoscopy at the ... Endoscopy Centers in 87th Ave., Miami, FL. , The HyGIeaCare® Prep, ...
(Date:3/24/2017)... Texas (PRWEB) , ... March 24, 2017 , ... ... 2017 the year of enhancements, upgrading their training and leads programs. , In ... University. Reserved for elite sales agents, Performance Partners is designed to teach how ...
(Date:3/24/2017)... ... March 24, 2017 , ... ... Certified Medical Reiki™ Master in Frederick, MD. Judy says, “I am passionate about ... what is often a very difficult and challenging time.” , A Certified Medical ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... -- HealthMine surveys with 9,250 insured consumers fielded from February ... want help from their plans in five key areas: ... 2) help closing gaps in care, 3) better digital ... relevant, real-time guidance. Meeting these needs is essential to ... A Reason to Stay Engaged in Health ...
(Date:3/24/2017)... , March 23, 2017  Mirabilis Medical, ... advanced medical technology for non-invasive surgery, announced today ... System for treatment of uterine fibroids throughout the ... had received approval from the US Food and ... the Mirabilis System in the United States.  The ...
(Date:3/24/2017)... 2017  Provectus Biopharmaceuticals, Inc. (OTCQB: PVCT, ... oncology and dermatology biopharmaceutical company, today disclosed terms ... Sheet (the "Definitive Financing") it entered into on ... stockholders, who are referred to in the Definitive ... filed with the Securities and Exchange Commission.   ...
Breaking Medicine Technology: